Tesirine

Tesirine is part of the antibody-drug conjugate loncastuximab tesirine-lpyl (Zynlonta), used to treat relapsed or refractory adult large B-cell lymphoma (DLBCL) after at least two prior systemic therapies. It targets CD19 proteins on lymphoma cells, delivering the tesirine chemotherapy drug directly to cancer cells to kill them. The directory classifies it as a under development API with a synthetic source/manufacturing origin. Other names for this substance include Zynlonta. Its PubChem CID is 73672523.

CAS No 1595275-62-9
Molecular Formula C75H101N9O23
Molecular Weight 1496.6 g/mol
Synonyms [4-[[(2S)-2-[[(2S)-2-[3-[2-[2-[2-[2-[2-[2-[2-[2-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoylamino]-3-methylbutanoyl]amino]propanoyl]amino]phenyl]methyl (6S,6aS)-3-[5-[[(6aS)-2-methoxy-8-methyl-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-6-hydroxy-2-methoxy-8-methyl-11-oxo-6a,7-dihydro-6H-pyrrolo[2,1-c][1,4]benzodiazepine-5-carboxylate

Frequently Asked Questions